Get the Flash Player to see this player.
Content Providers
Sponsors
Company News
Globes, 20/11/2014 - Israel Discount Bank profit falls
Third quarter profit in 2014 was NIS 234 million, down from NIS 274 million in the corresponding quarter. More Info

Globes, 18/11/2014 - Mizrahi Tefahot reports slight rise in profit
The bank reported record quarterly revenue of NIS 1.3 billion in the third quarter. More Info

Globes, 13/11/2014 - Elbit Systems reports lower revenue and profit
The defense electronics company's order backlog has risen to $6.2 billion. More Info

Seeking Alpha, 12/11/2014 - Partner Communications' (PTNR) CEO Haim Romano on Q3 2014 Results - Earnings Call Transcript
More Info

Globes, 12/11/2014 - Partner revenue, subscriber numbers decline
Partner CEO Haim Romano: The company is taking a variety of measures to cope with the changing market reality . More Info

Globes, 12/11/2014 - Cellcom sees revenue eroded but profit rises
Streamlining led to a substantial rise in Cellcom's third quarter profit despite a 6.7% decline in revenue. More Info

Seeking Alpha, 12/11/2014 - Partner Communications Company (PTNR) Q3 2014 Results - Earnings Call Webcast
More Info

Globes, 12/11/2014 - Tshuva in Australia for talks with Woodside
The Delek Group controlling shareholder's meeting with Woodside is not believed to concern the Leviathan gas reserve. More Info

Business in Brief - Supermarket chain Shufersal slides to quarterly loss Haaretz.com, 12/11/2014 - Business in Brief - Supermarket chain Shufersal slides to quarterly loss
More Info

Globes, 11/11/2014 - Elbit Systems wins $29m US Air Force deal
The five year contract is for logistics support of the USAF’s F-16 head-up display electric module assemblies. More Info

Globes, 11/11/2014 - Shufersal again reports weak results
Supermarket chain Shufersal saw its third quarter sales revenue decline 2.8%, and posted a net loss. More Info

Osem warms to idea of bringing ice cream plant to hard-hit Arad Haaretz.com, 2/11/2014 - Osem warms to idea of bringing ice cream plant to hard-hit Arad
More Info

Seeking Alpha, 30/10/2014 - Teva Pharmaceutical Industries' (TEVA) CEO Erez Vigodman on Q3 2014 Results - Earnings Call Transcript
More Info

Teva Q3 profit beats estimates, raises 2014 forecast Haaretz.com, 30/10/2014 - Teva Q3 profit beats estimates, raises 2014 forecast
More Info

Zacks, 9/10/2014 - Teva Starts Rolling Submission of its Pain Drug CEP-33237 - Analyst Blog
More Info

Seeking Alpha, 9/10/2014 - Teva: Overlooked And Potentially Undervalued
More Info

Seeking Alpha, 9/10/2014 - Teva: Overlooked And Potentially Undervalued
More Info

In bid to cut costs, Teva to halt R&D in women's health and oncology Haaretz.com, 7/10/2014 - In bid to cut costs, Teva to halt R&D in women's health and oncology
More Info

Globes, 6/10/2014 - Teva halts oncology and women's health R&D
Teva is axing 14 pipeline projects to save $550 million over the next three years. More Info

Globes, 8/9/2014 - Partner recognizes Histadrut workers committee
Histadrut chairman: The wave of unionization that we see in the economy is part of the genuine social revolution. More Info

Globes, 7/9/2014 - Strauss to compensate Carmit on Cadbury chocolate
Strauss will pay Carmit NIS 9 million, and buy Carmit products for NIS 50 million following antitrust violations. More Info

Globes, 4/9/2014 - Migdal writes off NIS 7.5m on Dragon Ventures
Migdal Capital Markets closed the hedge fund down after chief investment officer Yaakov Weinstein left. More Info

Globes, 4/9/2014 - Kamada plunges on lung treatment results
The company confirmed that its AAT product for hereditary emphysema did not meet its Phase II/III trial endpoints. More Info

Globes, 4/9/2014 - Bronfman sells 6% stake in Discount Bank
Matthew Bronfman sold the shares for NIS 360 million through Citi. More Info

Globes, 3/9/2014 - Shufersal fires dozens, cuts salaries
CEO Yitzchack Abercohen said the steps will return the chain to growth and prevent continued erosion in financial results. More Info

Globes, 3/9/2014 - Teva reports positive Phase III asthma drug results
Teva will seek FDA and European approval for reslizumab as soon as possible. More Info

Globes, 3/9/2014 - English High Court backs Teva on AstraZeneca inhaler
The ruling against AstraZeneca's patent will facilitate the launch of Teva's DuoResp Spiromax asthma treatment. More Info

Shufersal cutting salaries as it trims down to compete with discounters Haaretz.com, 3/9/2014 - Shufersal cutting salaries as it trims down to compete with discounters
More Info

Globes, 1/9/2014 - UBS: Teva hiked Copaxone price 9.9%
Teva is battling generic versions of the 20 mg and 40 mg dosages of its MS blockbuster. More Info

Globes, 1/9/2014 - Osem sells less than Strauss, but earns more
There was marked improvement in Osem’s operations abroad in the first half year. More Info

Find Company by Name:
Find Company by Industry:
Find Company by Stock Exchange:
Find Company by Index:
language: German French Spanish
Sign-up for free digital directories
Sign-up to receive free newsletter

© Copyright 2014 | Terms & Conditions | Site Map | Contact Us | Tel Aviv Stock Exchange | Find a lawyer in Israel | Find a CPA in Israel | News releases from Israel Created by: Logics - פיתוח תוכנה ואינטרנט



Reprinted from the Equities Israel web site - www.equities.co.il